Looking to simplify sterile product development? Discover how Blow-Fill-Seal (BFS) technology accelerates innovation, enhances sterility, and reduces reliance on preservatives — across ophthalmology, ENT, biologics, and more. This whitepaper shows how Blow-Fill-Seal (BFS) technology is transforming the development of sterile, preservative-free, single-use pharmaceuticals. From ophthalmic and respiratory treatments to complex biologics, BFS offers a scalable, cost-effective, and patient-safe alternative to traditional aseptic filling.Written for pharmaceutical developers and technical teams, it combines technical insights, expert contributions, and a real-world case study to help you evaluate BFS for your next project. What you’ll learn: Key principles and advantages of BFS technology in sterile manufacturing Technical considerations for formulation and device integration A step-by-step case study: developing an injectable via BFS Regulatory and operational considerations for successful implementation Written for: Pharmaceutical developers, formulators, and technical leads. Contributors: Unither’s experts in R&D, operations, quality, regulatory, and supply chain. Complete the form to access your free copy.
